GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intelligent Bio Solutions Inc (NAS:INBS) » Definitions » EBIT per Share

INBS (Intelligent Bio Solutions) EBIT per Share : $-35.22 (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Intelligent Bio Solutions EBIT per Share?

Intelligent Bio Solutions's EBIT per Share for the three months ended in Sep. 2024 was $-8.40. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was $-35.22.

During the past 3 years, the average EBIT per Share Growth Rate was 63.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 33.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Intelligent Bio Solutions's EBIT per Share or its related term are showing as below:

INBS' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -14.8   Med: -4.15   Max: 63.2
Current: 63.2

During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Intelligent Bio Solutions was 63.20% per year. The lowest was -14.80% per year. And the median was -4.15% per year.

INBS's 3-Year EBIT Growth Rate is ranked better than
94.82% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.75 vs INBS: 63.20

Intelligent Bio Solutions's EBIT for the three months ended in Sep. 2024 was $-2.67 Mil.


Intelligent Bio Solutions EBIT per Share Historical Data

The historical data trend for Intelligent Bio Solutions's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelligent Bio Solutions EBIT per Share Chart

Intelligent Bio Solutions Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EBIT per Share
Get a 7-Day Free Trial -63.61 -138.77 -136.49 -124.30 -6.29

Intelligent Bio Solutions Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.35 -24.61 -1.42 -0.79 -8.40

Intelligent Bio Solutions EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Intelligent Bio Solutions's EBIT per Share for the fiscal year that ended in Jun. 2024 is calculated as

EBIT per Share(A: Jun. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-10.024/1.593
=-6.29

Intelligent Bio Solutions's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

EBIT per Share(Q: Sep. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-2.672/0.318
=-8.40

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intelligent Bio Solutions  (NAS:INBS) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Intelligent Bio Solutions EBIT per Share Related Terms

Thank you for viewing the detailed overview of Intelligent Bio Solutions's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Intelligent Bio Solutions Business Description

Traded in Other Exchanges
N/A
Address
135 West, 41ST Street, 5th Floor, New York, NY, USA, 10036
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).
Executives
Harry Simeonidis director, officer: CEO, President 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Foundation Ma-ran 10 percent owner 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
Gary W. Rollins Foundation 10 percent owner 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
David A Jenkins director P.O. BOX 682838, PARK CITY UT 84068
Jason Isenberg director 1908 CLIFF VALLEY WAY NE, ATLANTA GA 30329
Spiro Kevin Sakiris officer: Chief Financial Officer 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Life Science Biosensor Diagnostics Pty Ltd 10 percent owner LEVEL 9, 85 CASTLEREAGH STREET, SYDNEY C3 2000
Tom Parmakellis director 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Victoria Gavrilenko director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
Christopher Towers director 1981 MARCUS AVENUE, SUITE 130, LAKE SUCCESS NY 11042
Lawrence B Fisher director C/0 FINANCIAL FEDERAL CORP, 733 THIRD AVENUE, NEW YORK NY 10017
Leonard Victor Kempler director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
George Margelis director 708 THIRD AVENUE, 6TH FLOOR, NEW YORK CITY NY 10017
Boyages Steven Constantine director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017
Jonathan Scott Hurd director 708 THIRD AVENUE,, 6TH FLOOR, NEW YORK CITY NY 10017

Intelligent Bio Solutions Headlines

From GuruFocus